The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic non-small cell lung cancer.
 
Sree Siva Kumar Raja Addagalla
No Relationships to Disclose
 
Anokhi Shah
No Relationships to Disclose
 
Nandini Menon
No Relationships to Disclose
 
Minit Shah
No Relationships to Disclose
 
Ankush Shetake
No Relationships to Disclose
 
Supriya Goud
No Relationships to Disclose
 
Amit Joshi
No Relationships to Disclose
 
Vanita Noronha
Research Funding - AstraZeneca (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Nanobiotix (Inst); Novartis (Inst); Roche India (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology
 
Kumar Prabash
Research Funding - Alkem Laboratories (Inst); Aurigene Oncology Limited (Inst); BDR Pharmaceutics (Inst); Biocon (Inst); Dr. Reddy's Laboratories (Inst); Fresenius Kabi (Inst); Johnson and Johnson (Inst); NATCO Pharma (Inst); Roche (Inst)